GABRIELLA KOYENOVA: Open Payments
NPI 1598280489 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 66 payments from 13 companies in 2025. Trend: 2023 $726 · 2024 $1,198 · 2025 $1,288
Food & beverage: $1,223Education: $65
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $352 |
| Arcutis Biotherapeutics, Inc. | 14 | $216 |
| Incyte Corporation | 9 | $197 |
| Janssen Biotech, Inc. | 4 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $94 |
| GENZYME CORPORATION | 3 | $66 |
| Botanix SB Inc | 3 | $66 |
| Organon LLC | 3 | $54 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: OTEZLA, Zoryve, OPZELURA, DUPIXENT, TREMFYA, SOFDRA, VTAMA, Winlevi.
Industry payments across NY — which companies pay providers there.
